Mednax Inc (MD) Gets a Hold Rating from Mizuho Securities

By Austin Angelo

Mizuho Securities analyst Ann Hynes reiterated a Hold rating on Mednax Inc (MDResearch Report) on January 25 and set a price target of $38. The company’s shares opened today at $36.70, close to its 52-week low of $31.68.

According to TipRanks.com, Hynes is a 3-star analyst with an average return of 2.1% and a 50.0% success rate. Hynes covers the Services sector, focusing on stocks such as Quest Diagnostics Inc, Acadia Healthcare, and Diplomat Pharmacy.

The word on The Street in general, suggests a Hold analyst consensus rating for Mednax Inc with a $42.10 average price target, a 14.7% upside from current levels. In a report issued on January 17, Jefferies also maintained a Hold rating on the stock with a $39 price target.

See today’s analyst top recommended stocks >>

Mednax Inc’s market cap is currently $3.29B and has a P/E ratio of 9.95. The company has a Price to Book ratio of 1.09.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

MEDNAX, Inc. provides physician services including newborn, anesthesia, maternal-fetal, tele radiology, pediatric cardiology and other pediatric subspecialty care. The company’s solution include anesthesiology & pain management, prenatal, neonatal, pediatric, radiology, tele radiology, revenue cycle management and perioperative improvement consulting.